Transforming the Course of Pompe: Advancements in the Care of Evolving Phenotypes for Patients With Late-Onset Disease
Program DescriptionNewborn screening (NBS) for Pompe disease (PD) enables earlier diagnosis and life-saving treatments, revealing a higher prevalence than previously known.
Category
Format
Credits
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Cost $0.00
Lost in Transition: Pearls From An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy
Program DescriptionHistorically, patients with the most severe forms of spinal muscular atrophy (SMA) were largely unable to survive into adulthood, and those that did often were treated with a palliative approach.
Category
Format
  • Conference / meeting
  • Webinar live
Credits
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
Cost $0.00
Overburdened, Undertreated: Developments in the Patient-Centered Management of Spasticity in Multiple Sclerosis
Program DescriptionOver 80% of patients with multiple sclerosis (MS) experience related spasticity.
Category
Format
Credits
Cost $0.00
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum
Program DescriptionThe understanding of MS pathophysiology h
Category
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Attendance
Cost $0.00
Navigating the Clinic: Applying Modern Evidence, Expert Insights, and Practice Simulations to Optimize Idiopathic Hypersomnia Management
Due to the unique educational design of this course, the content must be viewed and completed on the myCME platform.Program DescriptionIdio
Category
Format
Credits
Cost $0.00
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success
Program DescriptionThe understanding and prognosis of patients with myasthenia gravis (MG) have made dramatic leaps since the advent of serological evaluation and immunotherapy.
Category
Format
Credits
Cost $0.00
Unlocking the Alzheimer’s Brain: How Radiological Tools and Biomarkers Hold the Key to Early Diagnosis and Decision-Making
Program DescriptionThe age of disease-modifying therapy in Alzheimer’s disease (AD) is now a reality with two amyloid beta targeting therapies (ATT) now approved. Both agents require early diagnosis and therapeutic initiation to exert their effects.
Category
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Cost $0.00
Over-Impacted, Under-Represented: Addressing Health Disparities in Multiple Sclerosis
Program DescriptionThe prevalence of multiple sclerosis (MS) in racial and ethnic minority groups appears to be growing and its prognosis among these groups is often worse.
Category
Format
Credits
Cost $0.00
Decoding CIDP Strategies to Overcome Common Diagnostic and Therapeutic Pitfalls
Due to the unique educational design of this course, the content must be viewed and completed on the myCME platform.Program DescriptionChronic inflammatory d
Category
Format
Credits
Cost $0.00

Pages